BD Fiscal Q3 Revenues Jump 45 Percent on CareFusion Buy | GenomeWeb

NEW YORK (GenomeWeb) – Becton Dickinson said today that its fiscal third quarter revenues grew 45 percent year over year largely on its recent acquisition of medical technology firm CareFusion.

For the three months ended June 30, BD recorded revenues of $3.12 billion compared to $2.16 billion in fiscal Q3 2014, and just shy of the consensus analysts' estimate of $3.13 billion. On a comparable, currency-neutral basis, adjusted revenues grew just over 2 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.